198 related articles for article (PubMed ID: 24120535)
1. Epidemiology of enterovirus 71 infections in Taiwan.
Chia MY; Chiang PS; Chung WY; Luo ST; Lee MS
Pediatr Neonatol; 2014 Aug; 55(4):243-9. PubMed ID: 24120535
[TBL] [Abstract][Full Text] [Related]
2. Reemergence of enterovirus 71 epidemic in northern Taiwan, 2012.
Luo ST; Chiang PS; Chung WY; Chia MY; Tsao KC; Wang YH; Lin TY; Lee MS
PLoS One; 2015; 10(3):e0116322. PubMed ID: 25774888
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development.
Huang ML; Chiang PS; Chia MY; Luo ST; Chang LY; Lin TY; Ho MS; Lee MS
PLoS Negl Trop Dis; 2013; 7(2):e2067. PubMed ID: 23459633
[TBL] [Abstract][Full Text] [Related]
4. Development of a high-growth enterovirus 71 vaccine candidate inducing cross-reactive neutralizing antibody responses.
Chia MY; Chung WY; Wang CH; Chang WH; Lee MS
Vaccine; 2018 Feb; 36(9):1167-1173. PubMed ID: 29398272
[TBL] [Abstract][Full Text] [Related]
5. Monitoring antigenic variations of enterovirus 71: implications for virus surveillance and vaccine development.
Chia MY; Chung WY; Chiang PS; Chien YS; Ho MS; Lee MS
PLoS Negl Trop Dis; 2014 Jul; 8(7):e3044. PubMed ID: 25058733
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology of enterovirus 71 infection in the central region of Taiwan from 2002 to 2012.
Wu WH; Kuo TC; Lin YT; Huang SW; Liu HF; Wang J; Chen YM
PLoS One; 2013; 8(12):e83711. PubMed ID: 24391812
[TBL] [Abstract][Full Text] [Related]
7. Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008.
Huang SW; Hsu YW; Smith DJ; Kiang D; Tsai HP; Lin KH; Wang SM; Liu CC; Su IJ; Wang JR
J Clin Microbiol; 2009 Nov; 47(11):3653-62. PubMed ID: 19776232
[TBL] [Abstract][Full Text] [Related]
8. Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C viruses.
van der Sanden S; van der Avoort H; Lemey P; Uslu G; Koopmans M
J Gen Virol; 2010 Aug; 91(Pt 8):1949-1958. PubMed ID: 20375223
[TBL] [Abstract][Full Text] [Related]
9. Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy.
Liu P; Yuan Y; Cui B; Huo Y; Bian L; Chen L; Liu S; Wang C; Xu Y; Tedcastle A; Gao F; Mao Q; Martin J; Liang Z
Viruses; 2021 Apr; 13(5):. PubMed ID: 33919184
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai.
Zeng M; El Khatib NF; Tu S; Ren P; Xu S; Zhu Q; Mo X; Pu D; Wang X; Altmeyer R
J Clin Virol; 2012 Apr; 53(4):285-9. PubMed ID: 22265829
[TBL] [Abstract][Full Text] [Related]
11. Incidence rates of enterovirus 71 infections in young children during a nationwide epidemic in Taiwan, 2008-09.
Lee MS; Chiang PS; Luo ST; Huang ML; Liou GY; Tsao KC; Lin TY
PLoS Negl Trop Dis; 2012; 6(2):e1476. PubMed ID: 22348156
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of five subgenotypes of Enterovirus 71 by Taiwanese human plasma and Taiwanese plasma derived intravenous immunoglobulin.
Wu CY; Wang HC; Wang KT; Weng SC; Chang WH; Shih DY; Lo CF; Wang DY
Biologicals; 2013 May; 41(3):154-7. PubMed ID: 23515089
[TBL] [Abstract][Full Text] [Related]
13. Clinical and virological features of enterovirus 71 infections in Denmark, 2005 to 2008.
Badran SA; Midgley S; Andersen P; Böttiger B
Scand J Infect Dis; 2011 Aug; 43(8):642-8. PubMed ID: 21526904
[TBL] [Abstract][Full Text] [Related]
14. TAK - 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic mice.
Tamura K; Kohnoe M; Takashino A; Kobayashi K; Koike S; Karwal L; Fukuda S; Vang F; Das SC; Dean HJ
Vaccine; 2022 May; 40(24):3330-3337. PubMed ID: 35501179
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Ningbo, China, 2008-2011.
Ni H; Yi B; Yin J; Fang T; He T; Du Y; Wang J; Zhang H; Xie L; Ding Y; Gu W; Zhang S; Han Y; Dong H; Su T; Xu G; Cao G
J Clin Virol; 2012 Aug; 54(4):342-8. PubMed ID: 22652041
[TBL] [Abstract][Full Text] [Related]
16. Sequence analysis of the first C2 subgenogroup strain of enterovirus 71 isolated in Korea.
Lee JA; Yoon YS; Hyeon JY; Yoo JS; Lee SW; Lee JW; Lee SW
J Clin Virol; 2016 Dec; 85():13-16. PubMed ID: 27816018
[TBL] [Abstract][Full Text] [Related]
17. Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine.
Wang KT; Lin SJ; Wang HC; Chen PC; Lin JJ; Chiang JR; Chang CL; Shih DY; Lo CF; Wang DY
Biologicals; 2016 Jul; 44(4):183-190. PubMed ID: 27068365
[TBL] [Abstract][Full Text] [Related]
18. Detection of recombination breakpoints in the genomes of human enterovirus 71 strains isolated in the Netherlands in epidemic and non-epidemic years, 1963-2010.
van der Sanden S; van Eek J; Martin DP; van der Avoort H; Vennema H; Koopmans M
Infect Genet Evol; 2011 Jul; 11(5):886-94. PubMed ID: 21352955
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city.
Huang WC; Huang LM; Kao CL; Lu CY; Shao PL; Cheng AL; Fan TY; Chi H; Chang LY
J Microbiol Immunol Infect; 2012 Apr; 45(2):96-101. PubMed ID: 22154997
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology analysis of enterovirus 71 strains isolated in Dak Lak, Vietnam, 2011-2016.
Le TV; Nguyen VTT; Nguyen QH; Pham DT
J Med Virol; 2019 Jan; 91(1):56-64. PubMed ID: 30132913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
